z-logo
open-access-imgOpen Access
Is the onset of adverse effects of immunotherapy always bad news for the patients…?—certainly not!
Author(s) -
Paul Hofman
Publication year - 2019
Publication title -
annals of translational medicine
Language(s) - English
Resource type - Journals
eISSN - 2305-5847
pISSN - 2305-5839
DOI - 10.21037/atm.2019.01.14
Subject(s) - immunotherapy , medicine , adverse effect , oncology , tumor progression , cancer immunotherapy , identification (biology) , chemotherapy , cancer , biology , botany

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom